Zhejiang Hisoar Pharmaceutical Co Ltd (002099) — Net Asset Momentum
Zhejiang Hisoar Pharmaceutical Co Ltd (002099) recorded a net asset momentum of -8.4% as of December 2024, with net assets of CN¥5.13 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Zhejiang Hisoar Pharmaceutical Co Ltd (002099) shareholders funds for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Zhejiang Hisoar Pharmaceutical Co Ltd Net Asset Momentum (2003–2024)
This chart tracks Zhejiang Hisoar Pharmaceutical Co Ltd's year-over-year net asset growth across 22 annual reporting periods from 2003 to 2024. The most recent momentum reading is -8.4%, with net assets of CN¥5.13 Billion CNY as of December 2024. For live market cap and overall valuation, see market cap of Zhejiang Hisoar Pharmaceutical Co Ltd.
Annual Net Asset History for Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2024)
The table below shows the complete annual net asset history for Zhejiang Hisoar Pharmaceutical Co Ltd from 2003 to 2024, covering 22 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Zhejiang Hisoar Pharmaceutical Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥5.13 Billion | CN¥7.46 Billion | CN¥2.32 Billion | ▼ -8.4% |
| 2023 | CN¥5.60 Billion | CN¥7.52 Billion | CN¥1.92 Billion | ▼ -8.2% |
| 2022 | CN¥6.10 Billion | CN¥8.39 Billion | CN¥2.29 Billion | ▼ -0.1% |
| 2021 | CN¥6.11 Billion | CN¥8.02 Billion | CN¥1.91 Billion | ▲ +4.5% |
| 2020 | CN¥5.85 Billion | CN¥7.18 Billion | CN¥1.33 Billion | ▲ +2.2% |
| 2019 | CN¥5.72 Billion | CN¥6.75 Billion | CN¥1.02 Billion | ▲ +6.2% |
| 2018 | CN¥5.39 Billion | CN¥7.04 Billion | CN¥1.64 Billion | ▲ +4.8% |
| 2017 | CN¥5.14 Billion | CN¥7.47 Billion | CN¥2.32 Billion | ▲ +7.8% |
| 2016 | CN¥4.77 Billion | CN¥6.91 Billion | CN¥2.14 Billion | ▲ +33.5% |
| 2015 | CN¥3.57 Billion | CN¥4.83 Billion | CN¥1.26 Billion | ▲ +12.4% |
| 2014 | CN¥3.18 Billion | CN¥4.17 Billion | CN¥988.73 Million | ▲ +402.3% |
| 2013 | CN¥632.80 Million | CN¥2.11 Billion | CN¥1.48 Billion | ▼ -14.3% |
| 2012 | CN¥738.05 Million | CN¥1.92 Billion | CN¥1.18 Billion | ▲ +0.1% |
| 2011 | CN¥736.96 Million | CN¥1.44 Billion | CN¥698.17 Million | ▲ +15.5% |
| 2010 | CN¥638.04 Million | CN¥1.14 Billion | CN¥502.28 Million | ▲ +13.6% |
| 2009 | CN¥561.79 Million | CN¥996.27 Million | CN¥434.48 Million | ▲ +2.6% |
| 2008 | CN¥547.50 Million | CN¥1.01 Billion | CN¥465.58 Million | ▲ +1.8% |
| 2007 | CN¥538.06 Million | CN¥949.75 Million | CN¥411.69 Million | ▲ +3.6% |
| 2006 | CN¥519.27 Million | CN¥921.93 Million | CN¥402.66 Million | ▲ +183.8% |
| 2005 | CN¥182.96 Million | CN¥576.72 Million | CN¥393.76 Million | ▲ +38.6% |
| 2004 | CN¥132.03 Million | CN¥387.38 Million | CN¥255.35 Million | ▲ +55.3% |
| 2003 | CN¥85.03 Million | CN¥362.38 Million | CN¥277.36 Million | — |